Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PHARMATHENE, INC · Firm: PHARMATHENE, INC
Advocacy for Reauthorization of Pandemic and All Hazards Preparedness Act (PAHPA) in both House (HR 2405) and Senaete (S.1855). Advocay for funding in House and Senate Labor-HHS Appropriations bills for the Biodefense Advanced Research and Development Agency (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA)anthrax vaccine.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PHARMATHENE, INC · Firm: PHARMATHENE, INC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMATHENE, INC via PHARMATHENE, INC
2014 · fourth_quarter · Q4
Biodefense Funding and oversight
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2014 · third_quarter · 3A
Source: Senate LDA
Advocacy for Reauthorization of Pandemic All-Hazards Preparedness Act (PAHPA) in House (HR 2405) and Senate (S.1855). Advocacy for House and Senate Labor-HHS Appropriations funding allocation in FY-2013 and FY-2014 for the Biodefense Advanced Research and Development Authority (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PHARMATHENE, INC · Firm: PHARMATHENE, INC
Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2012 (PAHPRA) in U.S. House (HR 2405) and U.S. Senate (S.1855). Encourage continued funding for the Biodefense Advanced Research and Development Authority (BARDA) at HHS with the House Labor-HHS Appropriations Subcommittee and Senate HELP and Labor-HHS Appropriations Committee. Continued education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.
Advocacy in House and Senate for Bills to Reauthorize the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). Advocacy in Congress for HHS/BARDA funding in FY-2013 budget (Senate Labor-HHS Appropriations and House Labor-H Appropriations. Education for Members of Congress and Staff on biodefense medical countermeasures, especially anthrax recombinant vaccine.
House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PHARMATHENE, INC · Firm: PHARMATHENE, INC
House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PHARMATHENE, INC · Firm: PHARMATHENE, INC
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) in the House (H.R. 2405) and the Seante (S. 1855). Education and awareness of the need for medical countermeasures (MCM's) for chemcial and biological threats. Need for second generation recombinant anthrax vaccine (rPA).
House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin
House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.
S. 3678 Pandemic and All Hazards Preparedness Act now law - authorized advanced development funding for biodfense and infectious disease technologies. Plus-Up funding for our lead product Valortim.
Biodefense funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2014 · third_quarter · Q3
Biodefense funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2014 · second_quarter · Q2
biodefense
Biodefense
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PHARMATHENE, INC via PHARMATHENE, INC
2014 · first_quarter · Q1
FY-2015 Labor-HHS Appropriations Bills. Advocacy for enhanced funding of the Biomedical Advanced Research and Development Authority (BARDA) at HHS, funding of the Project BioShield Special Reserve Fund (SRF) for acquisition of medical countermeasure against biological and chemcial threats, and the funding related to pandemic influenza. Education of Members of Congress and their staff on a recombinant protective antigen (rPA) anthrax vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2013 · fourth_quarter · Q4
FY-2014 Appropriations Continuing Resolution ; Inclusion of anomalies for funding for Biomedical Advanced Research and Development Authority (BARDA) and funding for Project BioShield Special Reserve Fund (SRF) to fund medical countermeasure procurement in the Startegic National Stockpile. Funding for biodefense (BARDA/SRF) in the FY-2014 Appropriations Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2013 · third_quarter · Q3
Advocacy for Appropriations for Biomedical Advanced Research and Development Authority (BARDA) at HHS, as well as funding for Medical Countermeasure Special Reserve Fund (SRF) and funding for Pandemic Influenza. Education of House and Senate staff for anthrax recombinant protective antigen (rPA) vaccine, anthrax monoclonal antibody therapeutic and chemical nerve agent recombinant bioscavenger.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2013 · second_quarter · Q2
Advocacy for funding of Bioshield Special Reserve Fund (SRF) as authorized in the Pandemic and All-Hazards Preparedness Reauthorization Act 2013. Advocacy for funding of BARDA at HHS. Education of House and Senate staff on anthrax recombinant protective antigen vaccine and recombinant butyrlcholinesterase as an organophosphate bioscavneger for chemical nerve agent prophylaxis.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2013 · first_quarter · Q1
Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2013 (PAHPRA) in U.S. House and Senate. Encourage funding in FY-2014 Labor-HHS Appropriations Bill BARDA and fully funding the BioShield Special Reserve Fund (SRF) as authorized in PAHPRA. Meetings and advocacy for HHS/BARDA funding with Senate HELP Committee, Senate labor-HHS Approps and House Appropriations Committee.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2012 · fourth_quarter · Q4
Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2012 (PAHPRA) in U.S. House (HR 2405) and U.S. Senate (S.1855). Encourage continued funding for the Biodefense Advanced Research and Development Authority (BARDA) at HHS with the House Labor-HHS Appropriations Subcommittee and Senate HELP and Labor-HHS Appropriations Committee. Continued education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2012 · third_quarter · Q3
Advocacy for Reauthorization of Pandemic All-Hazards Preparedness Act (PAHPA) in House (HR 2405) and Senate (S.1855). Advocacy for House and Senate Labor-HHS Appropriations funding allocation in FY-2013 and FY-2014 for the Biodefense Advanced Research and Development Authority (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2012 · second_quarter · Q2
Advocacy for Reauthorization of Pandemic and All Hazards Preparedness Act (PAHPA) in both House (HR 2405) and Senaete (S.1855). Advocay for funding in House and Senate Labor-HHS Appropriations bills for the Biodefense Advanced Research and Development Agency (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA)anthrax vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2012 · first_quarter · Q1
Advocacy in House and Senate for Bills to Reauthorize the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). Advocacy in Congress for HHS/BARDA funding in FY-2013 budget (Senate Labor-HHS Appropriations and House Labor-H Appropriations. Education for Members of Congress and Staff on biodefense medical countermeasures, especially anthrax recombinant vaccine.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2011 · third_quarter · 3A
House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2011 · second_quarter · 2A
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization in House and Senate. FY-2012 Funding for Biomedical Advanced Research and Development Authority (BARDA) at HHS (Labor-HHS in Senate and House Appropriations). Education of Members of Congress and Staff on bioterroism threat.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2011 · fourth_quarter · Q4
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) in the House (H.R. 2405) and the Seante (S. 1855). Education and awareness of the need for medical countermeasures (MCM's) for chemcial and biological threats. Need for second generation recombinant anthrax vaccine (rPA).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2011 · third_quarter · Q3
House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2011 · second_quarter · Q2
Pandemic and All-Hazards Preparedness Act (PAHPA) Reautorization in House and Senate. FY-2012 Funding for Biomedical Research and Development Authority (BARDA) at HHS. (Labor-HHS in Senate and and House Appropriations). Eductaion of Members of Congress and Staff on bioterrorism threat.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2010 · third_quarter · Q3
BARDA (Biodefense Advanced Research and Development AUthority) funding in FY-2011 Senate Labor-HHS Appropriations Bill; Education on bioterrorism threat to the nation and advocacy for procurement of late-stage vaccine and therapeutic technology; Retention of Project BioShield Special Reserve (SRF) Funds and their replenishment;DoD CBMS funding for organophosphate bioscavenger for chemcial nerve agents.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2010 · second_quarter · Q2
BARDA (Biodefense Advanced Research and Development Authority) funding in FY-2011 Labor-HHS Appropriations Bill; Biodefense threat to the nation and education on vaccines and therapeutics; Project BioShield Special Reserve Fund (SRF) replenishment and sustainability; Dept of Defense Chem-Bio Medical Systems (CBMS) funding for organophosphate bioscavenger against chemical nerve agents.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2010 · first_quarter · 1A
HHS - Biodefense Research and Development Authority FY-2011 funding. Anthrax vaccine (rPA) development contract modification. Chemical nerve agent bioscavenger FY-2011Defense Appropriations funding. Senate HELP Committee, biodefense awareness of threat and funding for medical countermeasures. Senate Labor-HHS appropriations. House Labor-HHS Aproppriations. House and Senate Homeland Security Committees (biodefense education and funding). E&C Health Subcomm.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2008 · second_quarter · Q2
BIODEFENSE, PROJECT BIOSHIELD, BARDA, FOOD CONSERVATION AND ENERGY ACT
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2008 · first_quarter · Q1
Biodefense, Project Bioshield, BARDA appropriations
Filing targets: Defense Threat Reduction Agency (DTRA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2008 · second_quarter · RA
Biodefense, Project BioShield, BARDA
PHARMATHENE, INC via PHARMATHENE, INC
2007 · year_end · YY
Biodefense, Project BioShield, advanced development funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2007 · year_end · YA
S. 3678 Pandemic and All Hazards Preparedness Act now law - authorized advanced development funding for biodfense and infectious disease technologies. Plus-Up funding for our lead product Valortim.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2006 · year_end · YY
S, 3678 - the Pandemic and All Hazards Preparedness Act. This bill now law authroized a new advancded development authority for biodfense and infectious disease technologies.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2006 · mid_year · RA
PHARMATHENE, INC via PHARMATHENE, INC
2005 · year_end · YY
Project BioShield
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2005 · mid_year · MM
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2004 · mid_year · MM
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
PHARMATHENE, INC via PHARMATHENE, INC
2004 · mid_year · RA
PHARMATHENE, INC via PHARMATHENE, INC
2004 · mid_year · RR